Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries

…, GB Migliori, D Mosca, YD Mukadi… - European …, 2015 - Eur Respiratory Soc
Latent tuberculosis infection (LTBI) is characterised by the presence of immune responses
to previously acquired Mycobacterium tuberculosis infection without clinical evidence of …

Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa

YD Mukadi, D Maher, A Harries - Aids, 2001 - journals.lww.com
Background Tuberculosis is a leading cause worldwide of morbidity and mortality among
HIV-infected people. The HIV era has seen a dramatic increase of the tuberculosis case fatality …

GeneXpert for TB diagnosis: planned and purposeful implementation

…, S Van Kampen, TM Shinnick, YD Mukadi - … Health: Science and …, 2013 - ghspjournal.org
Xpert MTB/RIF is a major advance for TB diagnostics, especially for multidrug-resistant (MDR)
TB and HIV-associated TB. But implementation concerns including cost, technical support …

[HTML][HTML] Pulmonary tuberculosis in HIV-infected patients in Zaire—a controlled trial of treatment for either 6 or 12 months

JH Perriëns, ME St. Louis, YB Mukadi… - New England journal …, 1995 - Mass Medical Soc
Background We studied the efficacy of a short-course regimen of chemotherapy for pulmonary
tuberculosis in Kinshasa, Zaire. We also assessed whether, among patients with human …

[HTML][HTML] Population-based resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones: results from a multicountry surveillance project

…, S Tahseen, WA Wells, YD Mukadi… - The Lancet infectious …, 2016 - thelancet.com
Background Pyrazinamide and fluoroquinolones are essential antituberculosis drugs in new
rifampicin-sparing regimens. However, little information about the extent of resistance to …

[HTML][HTML] Genetic sequencing for surveillance of drug resistance in tuberculosis in highly endemic countries: a multi-country population-based surveillance study

…, TA Kohl, M Mansjö, P Miotto, YD Mukadi… - The Lancet Infectious …, 2018 - thelancet.com
Background In many countries, regular monitoring of the emergence of resistance to anti-tuberculosis
drugs is hampered by the limitations of phenotypic testing for drug susceptibility. …

Impact of HIV infection on the development, clinical presentation, and outcome of tuberculosis among children in Abidjan, Côte d'Ivoire.

YD Mukadi, SZ Wiktor, IM Coulibaly… - AIDS (London …, 1997 - europepmc.org
Impact of HIV infection on the development, clinical presentation, and outcome of tuberculosis
among children in Abidjan, Côte d'Ivoire. - Abstract - Europe PMC Sign in | Create an account …

[HTML][HTML] Antiretroviral therapy enrollment characteristics and outcomes among HIV-infected adolescents and young adults compared with older adults—seven African …

…, P Ehrenkranz, G Bicego, K Torpey, YD Mukadi… - MMWR Morb Mortal …, 2014 - cdc.gov
Although scale-up of antiretroviral therapy (ART) since 2005 has contributed to declines of
about 30% in the global annual number of human immunodeficiency (HIV)-related deaths …

[HTML][HTML] Adherence support workers: a way to address human resource constraints in antiretroviral treatment programs in the public health setting in Zambia

…, AJ Mwango, J Simpungwe, C Suzuki, YD Mukadi - PloS one, 2008 - journals.plos.org
Background In order to address staff shortages and improve adherence counseling for people
on antiretroviral therapy (ART), the Zambia Prevention, Care and Treatment Partnership (…

Incomplete adherence among treatment-experienced adults on antiretroviral therapy in Tanzania, Uganda and Zambia

…, S Tsui, J Menten, K Torpey, E Van Praag, YD Mukadi… - Aids, 2015 - journals.lww.com
Objectives: To characterize antiretroviral therapy (ART) adherence across different programmes
and examine the relationship between individual and programme characteristics and …